VivoSeq
Other

Abnormal Uterine Bleeding

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Abnormal Uterine Bleeding is an early-stage landscape with 0 programs across 1 company. The most active players are ScinnoHub Pharmaceutical Co., Ltd..

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

ScinnoHub Pharmaceutical Co., Ltd.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed4 · 57%
Recruiting1 · 14%
Unknown status1 · 14%
Withdrawn1 · 14%

Clinical Trials

Trial Activity

7 trials

Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding
Recruiting·SScinnoHub Pharmaceutical Co., Ltd.·Phase 1·NCT07169214·39 enrolled
Nonsurgical Management of Cesarean Scar Niche Related Abnormal Uterine Bleeding
Completed·SSaudi German Hospital - Madinah·N/A·NCT05594186·158 enrolled
Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding
Completed·—·N/A·NCT07229209·166 enrolled
Abnormal Uterine Bleeding and Progestin-only Contraceptives
Completed·—·N/A·NCT03398811·390 enrolled
Management of Abnormal Uterine Bleeding
Completed·EEgymedicalpedia·N/A·NCT06369012·130 enrolled
CDB-2914 for Abnormal Uterine Bleeding in Premenopausal Women
Withdrawn·Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·Phase 1·NCT01493791
Cervical Ripening Before Endometrial Biopsy in Abnormal Uterine Bleeding Using Sublingual Misoprostol
Unknown status·MMahidol University·N/A·NCT01762319·52 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)